Zomedica Corp. (ZOMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0950
-0.0030 (-3.06%)
May 5, 2026, 3:52 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Diagnostics
2.80M2.43M1.38M391.00K125.00K
Diagnostics Growth
15.13%76.69%252.17%212.80%-
Therapeutics
26.20M24.85M23.81M18.54M4.01M
Therapeutics Growth
5.41%4.38%28.43%362.55%-
Development Services
3.03M----
Total
32.03M27.29M25.19M18.93M4.13M
Total Growth
17.39%8.33%33.05%358.02%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Foreign
5.57M4.73M---
Foreign Growth
17.76%----
United States
26.46M22.56M---
United States Growth
17.31%----
Total
32.03M27.29M---
Total Growth
17.39%----
Source: S&P Global Market Intelligence.